7447 — Nagaileben Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual income statement for Nagaileben Co, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.

	2019 August 31st	2020 August 31st	2021 August 31st	2022 August 31st	2023 August 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	16,786	17,066	17,563	17,745	17,182
Cost of Revenue
Gross Profit	7,841	7,810	8,059	7,882	7,547
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	11,877	12,129	12,369	12,724	12,577
Operating Profit	4,909	4,937	5,194	5,022	4,605
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4,988	5,030	5,289	5,468	4,672
Provision for Income Taxes
Net Income After Taxes	3,445	3,474	3,648	3,778	3,226
Net Income Before Extraordinary Items
Net Income	3,445	3,474	3,648	3,778	3,226
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3,445	3,474	3,648	3,778	3,226
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	104	106	111	116	100
Dividends per Share